Immunotherapy with concurrent subcutaneous GM-CSF, low-dose IL-2 and IFN-alpha in patients with progressive metastatic renal cell carcinoma.

Immunotherapy with concurrent subcutaneous GM-CSF, low-dose IL-2 and IFN-alpha in patients with progressive metastatic renal cell carcinoma.

Item
http://www.wikidata.org/entity/Q37340399
Immunomodulatory effects of human recombinant granulocyte-macrophage colony-stimulating factor (rhuGM-CSF): evidence of antitumour activity.Perioperative immunomodulation with interleukin-2 in patients with renal cell carcinoma: results of a controlled phase II trial.Current status of cytoreductive nephrectomy in metastatic renal cell carcinoma.Granulocyte macrophage colony-stimulating factor predicts postoperative recurrence of clear-cell renal cell carcinomaBacteriolytic therapy can generate a potent immune response against experimental tumors.Clinical uses of GM-CSF, a critical appraisal and update.Prediction of response to combined immunotherapy with interferon-alpha and low-dose interleukin-2 in metastatic renal cell carcinoma: expression patterns of potential molecular markers in radical nephrectomy specimens.Phase I/II trial of subcutaneous interleukin-2, granulocyte-macrophage colony-stimulating factor and interferon-α in patients with metastatic renal cell carcinoma.Integrative tumor board: metastatic renal cell carcinoma: naturopathic medicine.
P2860

Immunotherapy with concurrent subcutaneous GM-CSF, low-dose IL-2 and IFN-alpha in patients with progressive metastatic renal cell carcinoma.

Item
http://www.wikidata.org/entity/Q37340399
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2003
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Immunotherapy with concurrent ...... tastatic renal cell carcinoma.
@en
Immunotherapy with concurrent ...... tastatic renal cell carcinoma.
@nl
type
label
Immunotherapy with concurrent ...... tastatic renal cell carcinoma.
@en
Immunotherapy with concurrent ...... tastatic renal cell carcinoma.
@nl
prefLabel
Immunotherapy with concurrent ...... tastatic renal cell carcinoma.
@en
Immunotherapy with concurrent ...... tastatic renal cell carcinoma.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P577
P5875
P6179
P698
P921
P932
P356
P1433
P1476
Immunotherapy with concurrent ...... tastatic renal cell carcinoma.
@en
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P577
P5875
P6179
P698
P921
P932